Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Disposition to Issuer of 17,000 APTO shares, $29.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Aptose Biosciences Inc. (APTO) | Disposition to Issuer | 17,000 | $29.2K |
| Jun 17, 2026 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 3,135 | n/a |
| Jun 3, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/Award | 30,000 | n/a |
| Feb 13, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase | 60,000 | $49.6K |
| Jan 20, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase | 100,000 | $103.8K |
| Jun 9, 2025 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,045 | n/a |
| Oct 15, 2024 | Aprea Therapeutics, Inc. (APRE) | Purchase | 10,000 | $26.8K |
| Jun 21, 2024 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,045 | n/a |
| Mar 15, 2024 | Aprea Therapeutics, Inc. (APRE) | Purchase | 6,860 | $50.0K |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 3,333 | n/a |